1. Home
  2. HOTH vs UGRO Comparison

HOTH vs UGRO Comparison

Compare HOTH & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$4.60

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOTH
UGRO
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
13.2M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
HOTH
UGRO
Price
$0.65
$4.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
395.0K
128.8K
Earning Date
05-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
29.69
N/A
EPS
N/A
N/A
Revenue
N/A
$17,399,438.00
Revenue This Year
N/A
$462.72
Revenue Next Year
N/A
$86.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.11
52 Week High
$2.12
$39.68

Technical Indicators

Market Signals
Indicator
HOTH
UGRO
Relative Strength Index (RSI) 38.59 35.07
Support Level $0.49 $0.28
Resistance Level $0.80 $39.68
Average True Range (ATR) 0.04 0.81
MACD -0.00 -0.10
Stochastic Oscillator 11.82 0.00

Price Performance

Historical Comparison
HOTH
UGRO

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: